首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1374810

全球覆膜支架市場 -2023-2030

Global Covered Stents Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

覆膜支架是一種帶有織物塗層的血管支架，可形成封閉管，但可以像裸金屬支架一樣擴張。覆膜支架用於血管內外科手術，例如血管內動脈瘤修復術。覆蓋支架由覆蓋金屬支架的織物或移植材料（例如聚四氟乙烯（PTFE））組成。它們在周邊動脈疾病管理中具有多種臨床應用。

應用包括治療動脈粥狀硬化疾病、封閉醫源性血管穿孔或破裂、排除動脈瘤和假性動脈瘤、治療動靜脈瘻管、治療失敗的透析移植物。覆膜支架在先天性心臟介入治療期間使用，以治療狹窄或受傷的血管或排除不必要的血管連接。

覆蓋支架也用於治療天然冠狀動脈中充滿血栓的病變。覆膜支架為血管穿孔提供了有效的救助策略，是排除冠狀動脈瘤的手術的替代方案，並且在治療易碎易發生栓塞的斑塊方面具有潛在作用。

市場動態：促進因素與限制因素

冠狀動脈疾病盛行率上升

覆膜支架主要用於治療可能危及生命的冠狀動脈穿孔和冠狀動脈瘤。先前的研究表明，使用覆膜支架可提高無事件生存率，無需緊急手術即可處理危及生命的情況，並顯著降低死亡率、心臟壓塞和主要不良心臟事件的發生率

冠狀動脈疾病是由向心臟供血的動脈（稱為冠狀動脈）壁上斑塊積聚引起的。斑塊由膽固醇沉澱物組成。隨著時間的推移，斑塊的堆積會導致動脈內部變窄。這個過程稱為動脈粥狀硬化

例如，根據美國疾病管制與預防中心2023 年更新情況說明書，冠狀動脈心臟病是最常見的心臟病類型，2021 年將導致375,476 人死亡。20 歲及以上的成年人中約有二分之一患有CAD （約5%） .2 到 2021 年，大約十分之二的 CAD 死亡病例發生在 65 歲以下的成年人中。

此外，覆膜支架技術的進步、老年人口盛行率的上升、冠狀動脈疾病盛行率的增加以及支架置入術患者預後的改善。藥物洗脫支架 (DES) 技術的進步包括不斷完善現有平台，以改善支架輸送並開發更俱生物相容性的藥物聚合物。

市場動態：克制

覆膜支架最常見的失效機制是輸送失敗、支架移位和未能密封穿孔。 Graftmaster 的輸送失敗較常見，而 PK Papyrus 的支架移位較常見。需要進一步改善覆膜支架的設計，以最佳化輸送能力並最大限度地降低併發症的風險。

此外，這些專用醫療設備的成本很高。覆膜支架通常比傳統支架更昂貴，這可能會限制其採用，特別是在醫療保健預算有限的地區。此外，熟練部署覆膜支架的熟練介入性心臟病專家的數量有限，進一步阻礙了整個市場的發展。

Covered stent is a type of vascular stent with a fabric coating that creates a contained tube but is expandable like a bare metal stent. Covered stents are used in endovascular surgical procedures such as endovascular aneurysm repair. Covered stents are composed of fabric or graft material, such as polytetrafluoroethylene (PTFE), covering a metal stent. They have various clinical applications in peripheral arterial disease management.

Applications include treatment of atherosclerotic disease, sealing iatrogenic vessel perforations or ruptures, exclusion of aneurysms and pseudoaneurysms, treatment of arteriovenous fistulae, and management of failing dialysis grafts. Covered stents are used during congenital cardiac interventions to treat stenotic or injured vessels or to exclude unwanted vascular connections.

Covered stents were also utilised in thrombus-laden lesions in native coronary arteries. Covered stents offer an effective bail-out strategy in vessel perforations, are an alternative to surgery for the exclusion of coronary aneurysms, and have a potential role in the treatment of friable embolisation-prone plaques.

Market Dynamics: Drivers and Restraints

Rise in the prevalence of coronary artery diseases

Covered stents have been mainly used for the treatment of potentially life-threatening coronary artery perforation and coronary artery aneurysms. Prior studies suggest that the use of covered stents improves event-free survival, enabling a life-threatening situation to be managed without emergency surgery and with significantly reduced rates of mortality, cardiac tamponade, and major adverse cardiac events

Coronary artery disease is caused by plaque buildup in the wall of the arteries that supply blood to the heart (called coronary arteries). Plaque is made up of cholesterol deposits. Plaque buildup causes the inside of the arteries to narrow over time. This process is called atherosclerosis

For instance, according to the Centers for Disease Control and Prevention updated factsheet 2023, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. About 1 in 20 adults age 20 and older have CAD (about 5%).2 In 2021, about 2 in 10 deaths from CAD happen in adults less than 65 years old.

Furthermore, technological advancements in covered stents, the rise in the prevalence of the geriatric population, the increase in the prevalence of coronary artery diseases and improvement in patient outcomes with stenting. Advancements in drug-eluting stent (DES) technologies have consisted of continually refining existing platforms to improve stent delivery and develop more biocompatible drug polymers.

Market Dynamics: Restraint

The most common failure mechanisms of covered stents are failure of delivery, stent dislodgement, and failure to seal the perforation. Failure of delivery was more common with Graftmaster, while stent dislodgement was more common with PK Papyrus. Further improvements in covered stent design are needed to optimize deliverability and minimize the risk of complications.

Also, the high cost associated with these specialized medical devices. Covered stents are often more expensive than traditional stents, which can limit their adoption, particularly in regions with constrained healthcare budgets. Moreover, the limited availability of skilled interventional cardiologists proficient in deploying covered stents further hampers the overall market.

Segment Analysis

The global covered stents is segmented based on product type, material type, application, end-user and region.

The balloon expandable vascular-covered stent segment accounted for approximately 41.2% of the market share

The balloon expandable vascular covered stent from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Balloon Expandable Vascular Covered Stent is indicated for the treatment of atherosclerotic lesions in common and external iliac arteries. Balloon-expandable covered stents are medical devices used in interventional cardiology and vascular surgery to treat vascular conditions like aneurysms and stenoses. They consist of a metal framework covered with a synthetic fabric or polymer material.

Moreover, in September 2022, Medtronic set forth that it recently received a CE mark for its Radiant balloon-expandable covered stent, the first and currently only covered stent indicated for use in ChEVAR with the Endurant II/Iis stent graft system. The Endurant II/Iis stent graft and Radiant covered stent offer a standardized, fully on-label, off-the-shelf solution for short-neck, juxtarenal abdominal aortic aneurysms (AAA). This enables safe and effective endovascular repair in both urgent and elective juxtarenal AAA cases, with a proven device combination, backed by clinical outcomes.

Geographical Analysis

Europe accounted for approximately 28.4% of the market share in 2022

Europe is estimated to hold about 28.4% of the total market share throughout the forecast period, owing to the novel product launches, technological advancements, collaboration with the key players, approvals and others that will drive this region further during the forecast period.

For instance, in September 2022, Getinge joined forces with Medtronic to launch a Radiant stent for ChEVAR procedures in Europe which received a CE mark.

Radiant, is the first covered stent which is designed for use in chimney endovascular aneurysm repair (ChEVAR) with the Endurant II/Iis stent graft system. It maintains perfusion to renal arteries when used in combination with the stent graft

Furthermore, in May 2021, iVascular has recently received CE mark approval for its BX-covered stent iCover. Balloon-expanding (BX) covered stents are commonly used for treating arteriosclerotic lesions in renal and iliac arteries and for the treatment of aneurysms and ruptures.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global covered stents market importantly, new studies and registers shows that the percentage of stent thrombosis increased during the COVID-19 pandemic, even up to 8.1-21%, however, the study populations were relatively low. COVID-19, due to direct and indirect effects, creates a significant burden on the cardiovascular system.

Due to the high infection rate and lockdown regulations brought on by the COVID-19 pandemic, surgical procedures have been affected. Additionally, patients with cardiovascular diseases have experienced delays in diagnosis and treatment as a result of fewer people visiting hospitals and diagnostic facilities, which has affected the covered stent market.

Competitive Landscape

The major global players in the covered stents market include: Becton, Dickinson and Company, B. Braun Interventional Systems Inc., Getinge, Insrtumed Surgical, Inc., Boston Scientific Corporation, Biotronik, Mermaid Medical, Gore Medical, Getz Healthcare, iVascular S.L.U and among others.

Why Purchase the Report?

To visualize the global covered stents market segmentation-based product type, material type, application, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of covered stents market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global covered stents market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. Rise in the prevalence of coronary artery diseases
  - 4.1.1.2. Rise in the technology advancements
- 4.1.2. Restraints
  - 4.1.2.1. Side Effects of Toxoid Vaccine
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Balloon Expandable Covered Stents *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bare Metal Covered Stents
7.4. Drug-Eluting Covered Stents
7.5. Bioabsorbable Covered Stents

8. By Material Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 8.1.2. Market Attractiveness Index, By Material Type
8.2. ePTFE (Expanded Polytetrafluoroethylene) Covered Stents*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polyurethane
8.4. Polyester Covered Stents

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Peripheral Vascular Aneurysms *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Coarctation of the Aorta
9.4. Atherosclerotic Diseases
9.5. Coronary Artery Perforations

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers (ASCs)

11. Cardiac Specialty Clinics

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.7.1. U.S.
  - 12.2.7.2. Canada
  - 12.2.7.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.7.1. Germany
  - 12.3.7.2. UK
  - 12.3.7.3. France
  - 12.3.7.4. Italy
  - 12.3.7.5. Spain
  - 12.3.7.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.6.1. Brazil
  - 12.4.6.2. Argentina
  - 12.4.6.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.6.1. China
  - 12.5.6.2. India
  - 12.5.6.3. Japan
  - 12.5.6.4. Australia
  - 12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Becton, Dickinson and Company
- 14.1.1. Company Overview
- 14.1.2. Product Type Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. B. Braun Interventional Systems Inc
14.3. Getinge
14.4. Insrtumed Surgical, Inc
14.5. Boston Scientific Corporation
14.6. Biotronik
14.7. Mermaid Medical
14.8. Gore Medical
14.9. Getz Healthcare
14.10. avascular S.L.U

LIST NOT EXHAUSTIVE